Integrum AB (publ) (INTEG_B) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Integrum Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.736 Hello and welcome to today's webcast with Integrum, where the CEO Martin Hylsten and 00:00:03.736 -- 00:00:07.221 CFO Louise Wolin will present the report for the last quarter. 00:00:07.221 -- 00:00:09.103 After the presentation, there will be a Q&A. 00:00:09.103 -- 00:00:12.408 If you have any questions for the company, you can send them in the form to the right. 00:00:12.408 -- 00:00:15.810 And with that said, I hand over the floor to you. 00:00:16.333 -- 00:00:22.101 Hello, good morning, thank you for that. Welcome to Integrum's Q4 00:00:22.101 -- 00:00:27.545 report. For those who are new to Integrum, we are a Swedish medical technology 00:00:27.545 -- 00:00:30.974 company with roots in research as the basis for our integration. 00:00:30.974 -- 00:00:36.147 Our focus is to develop commercial bone-linked implantation systems for amputated prostheses 00:00:36.147 -- 00:00:40.565 directly connected to the skeleton, instead of via a traditional sleeve. 00:00:40.565 -- 00:00:45.910 Our main product, OPERA Implant System, is the only FDA-recognized implantation system 00:00:45.910 -- 00:00:51.096 for amputations in the US. By combining clinical research, innovation and long experience 00:00:51.096 -- 00:00:56.221 in the area, we are working to improve the function, mobility and quality of life for 00:00:56.221 -- 00:00:59.582 amputated patients around the world. 00:01:00.265 -- 00:01:04.990 Before we go into detail, I would like to take a step back and summarize what we have 00:01:04.990 -- 00:01:07.852 achieved over the past year. 00:01:07.852 -- 00:01:10.456 Året vi nu stänger har präglat av förändring. 00:01:10.456 -- 00:01:15.383 Vi har stärkt ledningen, förenklat organisationen och reducerat vår operativa kostnadsbas 00:01:15.38...